The RxGen Platform
Research Models & Capabilities that Truly Enable Clinical Translation
From discovery to development to post-market repositioning, RxGen has established a powerful preclinical platform to provide critical insight into the safety and efficacy of novel therapies, medical devices and delivery technologies to accelerate and strengthen the path to clinic and associated development decisions.
The RxGen Advantage
Scientific Engagement. Clinically Relevant Modeling. Timely Execution.
RxGen has advanced discovery and development programs for a wide range of sponsors, collaborators and partners, ranging from large pharmaceutical companies and venture-backed biotechnology companies to academic teams seeking to apply the most cutting edge research and development strategies in the most efficient and robust manner.
Our unique portfolio of models, combined with focused therapeutic domain expertise results in engagements that generate high value, clinically relevant data that yields definitive, actionable study outcomes.
We place ultimate value on scientific excellence and innovation and the effectiveness with which our resources and models are applied toward achieving objectives. All programs are pursued to the highest standards with full consideration of clinical objectives and animal welfare. RxGen is recognized for the quality of scientific engagement and capability applied to research and development programs.